Patents by Inventor Ruby Law

Ruby Law has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES FOR BINDING PLASMIN
    Publication number: 20230220112
    Abstract: The present invention provides an antigen binding protein comprising an antigen binding domain that binds to plasmin, wherein the antigen binding protein reduces the activity of plasmin. The invention also provides compositions comprising the antigen binding protein, and uses and method of treatment comprising the same.
    Type: Application
    Filed: October 28, 2020
    Publication date: July 13, 2023
    Inventors: James Whisstock, Ruby Law, Adam Quek, Paul Conroy, Guojie Wu
  • ANTIBODIES FOR BINDING PLASMINOGEN
    Publication number: 20220380484
    Abstract: The present invention relates to antigen binding proteins comprising an antigen binding domain that binds to plasminogen, wherein the antigen binding protein reduces the activation of plasminogen to plasmin, pharmaceutical compositions comprising the same, and methods and uses thereof.
    Type: Application
    Filed: October 28, 2020
    Publication date: December 1, 2022
    Inventors: James Whisstock, Ruby Law, Adam Quek, Paul Conroy, Dena Lyras, Guojie Wu
  • METHODS FOR MAKING RECOMBINANT PROTEIN
    Publication number: 20220267751
    Abstract: The present invention relates to methods of producing recombinant plasminogen in a mammalian expression system. A method for producing plasminogen, the method comprising (i) providing a host cell comprising a first recombinant polynucleotide encoding plasminogen and a second recombinant polynucleotide encoding a plasminogen activation inhibitor; (ii) culturing said host cell in a suitable culture medium under conditions to effect expression of plasminogen from the first polynucleotide and plasminogen activation inhibitor from the second polynucleotide.
    Type: Application
    Filed: July 10, 2020
    Publication date: August 25, 2022
    Applicant: Monash University
    Inventors: James Whisstock, Ruby Law, Adam Quek, Paul Conroy
  • Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylase
    Patent number: 6165738
    Abstract: An antigenically active hybrid glutamic acid decarboxylase (GAD) comprising an amino-terminal moiety derived from the GAD67 isoform linked directly or indirectly with a middle and carboxy-terminal moiety derived from the GAD65 isoform, and production thereof as a recombinant protein by expression in eukaryotic host cells, particularly yeasts.
    Type: Grant
    Filed: September 13, 1999
    Date of Patent: December 26, 2000
    Assignees: Montech Medical Developments Pty. Ltd., Rondole Pty. Ltd.
    Inventors: Ian Reay Mackay, Merrill Joy Rowley, Paul Zev Zimmet, Brian Corner, Ruby Law, Khay-Lin Teoh